Denmark
· Delayed Price · Currency is DKK Stenocare Statistics
Total Valuation
Stenocare has a market cap or net worth of DKK 44.36 million. The enterprise value is 51.23 million.
| Market Cap | 44.36M |
| Enterprise Value | 51.23M |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Stenocare has 19.98 million shares outstanding. The number of shares has increased by 13.76% in one year.
| Shares Outstanding | 19.98M |
| Shares Change (YoY) | +13.76% |
| Shares Change (QoQ) | +1.31% |
| Owned by Insiders (%) | 8.37% |
| Owned by Institutions (%) | n/a |
| Float | 8.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.16 |
| PB Ratio | 2.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.05 |
| EV / Sales | 15.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.27 |
Financial Position
The company has a current ratio of 0.68, with a Debt / Equity ratio of 0.38.
| Current Ratio | 0.68 |
| Quick Ratio | 0.40 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.72 |
| Interest Coverage | -6.07 |
Financial Efficiency
Return on equity (ROE) is -71.42% and return on invested capital (ROIC) is -30.50%.
| Return on Equity (ROE) | -71.42% |
| Return on Assets (ROA) | -29.23% |
| Return on Capital (ROIC) | -30.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.10 |
| Inventory Turnover | 12.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.69% in the last 52 weeks. The beta is 0.17, so Stenocare's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -41.69% |
| 50-Day Moving Average | 2.88 |
| 200-Day Moving Average | 3.77 |
| Relative Strength Index (RSI) | 28.72 |
| Average Volume (20 Days) | 32,211 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Stenocare had revenue of DKK 3.36 million and -16.81 million in losses. Loss per share was -0.99.
| Revenue | 3.36M |
| Gross Profit | -5.60M |
| Operating Income | -15.42M |
| Pretax Income | -17.96M |
| Net Income | -16.81M |
| EBITDA | -12.02M |
| EBIT | -15.42M |
| Loss Per Share | -0.99 |
Balance Sheet
The company has 153,500 in cash and 7.03 million in debt, giving a net cash position of -6.88 million or -0.34 per share.
| Cash & Cash Equivalents | 153,500 |
| Total Debt | 7.03M |
| Net Cash | -6.88M |
| Net Cash Per Share | -0.34 |
| Equity (Book Value) | 18.41M |
| Book Value Per Share | 1.01 |
| Working Capital | -2.47M |
Cash Flow
In the last 12 months, operating cash flow was -9.62 million and capital expenditures -90,802, giving a free cash flow of -9.71 million.
| Operating Cash Flow | -9.62M |
| Capital Expenditures | -90,802 |
| Free Cash Flow | -9.71M |
| FCF Per Share | -0.49 |
Margins
| Gross Margin | -166.68% |
| Operating Margin | -458.76% |
| Pretax Margin | -534.34% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -288.99% |
Dividends & Yields
Stenocare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.76% |
| Shareholder Yield | -13.76% |
| Earnings Yield | -44.79% |
| FCF Yield | -21.90% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Stenocare has an Altman Z-Score of 3.54.
| Altman Z-Score | 3.54 |
| Piotroski F-Score | n/a |